BindingDB logo
myBDB logout

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
21726077 51 The lipogenesis pathway as a cancer target.EBI Wayne State University
17521912 15 The biology and chemistry of hyperlipidemia.EBI Sinhgad College of Pharmacy
1479587 4 ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors.EBI SmithKline Beecham Pharmaceuticals Ltd.
17383874 15 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
9733484 39 ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.EBI SmithKline Beecham Pharmaceuticals Ltd
8784456 55 ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.EBI SmithKline Beecham Pharmaceuticals Ltd
7853346 13 Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.EBI SmithKline Beecham Pharmaceuticals Ltd.
2788743 6 Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids.EBI Hebrew University